Skip to content

"VALIDATION OF PRAMEHA POORVARUPA"

"VALIDATION OF POORVARUPA(PRODROMAL FEATURE) OF PRAMEHA - AN OBSERVATIONAL STUDY"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037707
Enrollment
100
Registered
2021-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E13- Other specified diabetes mellitus Health Condition 2: E13- Other specified diabetes mellitus

Interventions

None listed

Sponsors

Pt Khushilal Sharma Govt Auto Ayurveda College and Institute Bhopal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having one or more sign & symptoms of Prameha/ Diabetes 2. Patients aged between 31 â?? 60 years of either sex fulfilling diagnostic criteria. 3. Patients willing for participation in research activity with written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient not fulfilling the inclusion criteria 2. Pregnant and lactating women 3. Patient who had given history of systemic complicated disease like, Tuberculosis, HIV, any malignancy etc. 4. Patients not willing for participation in research activity with written informed consent

Design outcomes

Primary

MeasureTime frame
It is expected that at the end of the observational study we would be able to validate Poorvarupa. (Prodromal Feature) of Prameha in modern era and to explore the blood group relationship with Prameha patients.Timepoint: 12 month

Secondary

MeasureTime frame
It is further expected that this study will be helpful in clinical practice for the prevention of disease as well as its complications.Timepoint: 12 months

Countries

India

Contacts

Public ContactDr Rajesh Jain

Central council of indian medicine new delhi

sanjayayurvedabhopal@gmail.com9425012608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026